Aggrastat tirofiban: Phase IV data

In the single-blind, Italian STRATEGY Phase IV post-marketing trial in 175 patients with

Read the full 135 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE